COMMUNIQUÉS West-GlobeNewswire
-
Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free Protection
10/03/2026 -
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
10/03/2026 -
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
10/03/2026 -
NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer’s Disease at AD/PD™ 2026
10/03/2026 -
Propanc Biopharma Executes Service Agreement with FyoniBio to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study
10/03/2026 -
Experts at Park Mental Health Announce New Therapeutic Approach: Highlighting the Role of Community Support in Recovery
10/03/2026 -
Spectral AI Schedules 2025 Fourth Quarter and Full Year Financial Results and Conference Call
10/03/2026 -
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
10/03/2026 -
PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes
10/03/2026 -
Imprivata Introduces Agentic Identity Management to Secure and Govern AI Agents in Healthcare
10/03/2026 -
GLP Diet Review: A Personalized App Designed to Support GLP-1 Weight Loss Journeys
10/03/2026 -
HealthEdge HealthRules® Payer Works with AWS to Set a New Scalability Benchmark, Expanding to Support Health Plans with More Than 40 Million Members
10/03/2026 -
UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
10/03/2026 -
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
10/03/2026 -
Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia
10/03/2026 -
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
10/03/2026 -
Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
10/03/2026 -
Baylor Genetics Enhances Whole Genome Sequencing Test with Optical Genome Mapping and Long‑Read Sequencing as Supplemental Technologies
10/03/2026 -
Roche Annual General Meeting 2026
10/03/2026
Pages